Consensus guideline on concordance assessment of image guided breast biopsies and management of borderline or high risk lesions

The American Society of Breast Surgery has its own recommendations for B3 lesions (they do not use the term “B3”). The guidance is broadly the same but there are some subtle differences. The nomenclature has diverged, for example in the UK we favour the terms atypical intraductal epithelial proliferation (AIDEP) to atypical ductal hyperplasia. There are other related nomenclature differences. There is a lower threshold for surgical excision in these recommendations compared to the PHE guidance where vacuum assisted excision features strongly as a possible alternative to excision in appropriate patients.

Classifications: Screening & Diagnosis

Keywords: B3 Screening